BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5523954)

  • 1. [A new Soviet cytostatic drug--prospidine--used in treatment of Kaposi's angioreticulosis].
    Smelov NS; Kalamkarian AA
    Vestn Dermatol Venerol; 1970 Sep; 44(9):31-5. PubMed ID: 5523954
    [No Abstract]   [Full Text] [Related]  

  • 2. [A generalized form of Kaposi's angioreticulosis cured with prospidine].
    Kalamkarian AA; Makovoz VI
    Sov Med; 1971; 34(12):128-31. PubMed ID: 5148414
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of the cytostatic action preparation prospidine on urinary excretion of 17-hydroxycorticosteroids and 17-ketosteroids in reticulodermia].
    Soloveĭ SN; Kalamkarian AA; Zavadskiĭ VN
    Vestn Dermatol Venerol; 1973 Nov; 47(11):23-7. PubMed ID: 4779390
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antimitotic activity of prospidin].
    Ershova IuA; Minakova SM; Chernov VA
    Farmakol Toksikol; 1973; 36(1):78-81. PubMed ID: 4685159
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effectiveness of treating dermal reticulosis with prospidin and fotrin].
    Mukhamedov N
    Vestn Dermatol Venerol; 1973 Jan; 47(1):49-52. PubMed ID: 4575610
    [No Abstract]   [Full Text] [Related]  

  • 6. [Visceral lesions in Kaposi angioreticulosis and effect of prospidine therapy].
    Shaposhnikova OK; Rodionov AN
    Vestn Dermatol Venerol; 1977 Jul; (7):49-52. PubMed ID: 899237
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of different methods of treating Kaposi's angioreticulosis (Kaposi's sarcoma)].
    Kalamkarian AA
    Vestn Dermatol Venerol; 1971; 45(3):8-15. PubMed ID: 5122551
    [No Abstract]   [Full Text] [Related]  

  • 8. [Kaposi's angioreticulosis (sarcoma) (based on material from the Moldavian SSR Dermatovenerologic Dispensary, Kishinev)].
    Karalitskiĭ EM; Bragraenko AI; Luft IA
    Vestn Dermatol Venerol; 1982 Aug; (8):48-52. PubMed ID: 7148132
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Kaposi's sarcoma with ICRF-159 (NSC-129943).
    Olweny CL; Masaba JP; Sikyewunda W; Toya T
    Cancer Treat Rep; 1976 Jan; 60(1):111-3. PubMed ID: 1000514
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of cytostatic preparations in treating Kaposi's sarcoma by encircling injections].
    Shakhnes IE
    Vestn Dermatol Venerol; 1988; (11):28-9. PubMed ID: 3239226
    [No Abstract]   [Full Text] [Related]  

  • 11. [Kaposi's sarcoma. Prospidium chloride treatment].
    Fonseca Capdevila E; Alonso San Pablo MT; Casado Jiménez M; Soto Melo J
    Actas Dermosifiliogr; 1981; 72(3-4):167-70. PubMed ID: 7315580
    [No Abstract]   [Full Text] [Related]  

  • 12. Kaposi's sarcoma in rheumatic diseases.
    Louthrenoo W; Kasitanon N; Mahanuphab P; Bhoopat L; Thongprasert S
    Semin Arthritis Rheum; 2003 Apr; 32(5):326-33. PubMed ID: 12701043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-HIV-related Kaposi's sarcoma suppressed by dapsone.
    de Haas ER; de Wit RF; van Vloten WA
    Br J Dermatol; 1996 Nov; 135(5):813-4. PubMed ID: 8977690
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of T- and B-lymphocyte functional activity and of the rosette formation phenomenon in Kaposi's angioreticulosis].
    Reznikova LS; Stoianov VB
    Vestn Dermatol Venerol; 1979 Jul; (7):14-7. PubMed ID: 314713
    [No Abstract]   [Full Text] [Related]  

  • 15. A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma.
    Ben M'barek L; Fardet L; Mebazaa A; Thervet E; Biet I; Kérob D; Morel P; Lebbe C
    Dermatology; 2007; 215(3):202-5. PubMed ID: 17823515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir.
    Monini P; Sgadari C; Grosso MG; Bellino S; Di Biagio A; Toschi E; Bacigalupo I; Sabbatucci M; Cencioni G; Salvi E; Leone P; Ensoli B
    AIDS; 2009 Feb; 23(4):534-8. PubMed ID: 19169139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
    Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
    AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment update for AIDS-related Kaposi's sarcoma.
    Mihalcea AM; Smith DL; Monini P; Sgadari C; Ensoli B; Gill PS
    AIDS; 1999; 13 Suppl A():S215-25. PubMed ID: 10885778
    [No Abstract]   [Full Text] [Related]  

  • 19. Further experience with rezoxane (ICRF 159; -- NSC --129943) in treating Kaposi's sarcoma.
    Olweny CL; Sikyewunda W; Otim D
    Oncology; 1980; 37(3):174-6. PubMed ID: 7360489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.